Research & Development
Biogen's litifilimab receives FDA Breakthrough Therapy Designation for CLE
28 January 2026 - Biotechnology company Biogen Inc (Nasdaq:BIIB) announced on Wednesday that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for litifilimab (BII...
Glaukos receives FDA approval for repeat administration of iDose TR
28 January 2026 - Ophthalmic pharmaceuticals and medical technology company Glaukos Corporation (NYSE:GKOS) announced on Wednesday that the US Food and Drug Administration (FDA) has approved a new dru...
Guerbet's contrast agent Elucirem approved by European Commission in children from birth
28 January 2026 - French medical imaging company Guerbet (Euronext Paris:GBT) announced on Tuesday that it has received approval from the European Commission for a new indication in children from birt...
Spine Innovation's LOGIC Titanium Implant System receives US FDA 510(k) market approval
27 January 2026 - Spine Innovation LLC, a US-based medical device startup that develops novel interbody fusion implants, announced on Monday that it has received FDA 510(k) approval to market the LOGI...
Immusoft's ISP-002 receives US FDA Rare Pediatric Disease designation in mucopolysaccharidosis type II
27 January 2026 - Immusoft of CA, a clinical-stage biotechnology company developing engineered B cell therapies, announced on Monday that it has received Rare Pediatric Disease (RPD) designation from ...
United Therapeutics reports positive phase 1 data for bioengineered liver in acute liver failure
26 January 2026 - Pharmaceutical company United Therapeutics Corporation (Nasdaq: UTHR) on Monday reported positive results from a phase 1 clinical trial of miroliverELAP, an external liver assist pro...